Diagnostics, APIs, Small Molecules, Biosimilars
Total Trials
12
As Lead Sponsor
11
As Collaborator
1
Total Enrollment
1,392
NCT00709722
Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 31, 2003
Completion: Apr 30, 2007
NCT00530075
Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
Phase: Phase 2
Start: Dec 31, 2003
Completion: Feb 28, 2006
NCT00628121
Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer
Phase: N/A
Start: Apr 30, 2006
Completion: Feb 28, 2007
NCT00542958
Study of NK012 in Patients With Refractory Solid Tumors
Phase: Phase 1
Start: Mar 31, 2007
Completion: Dec 31, 2011
NCT00951054
A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Start: Feb 28, 2009
Completion: Feb 28, 2015
NCT01052259
Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection
Start: Jun 30, 2009
Completion: Dec 31, 2012
NCT00951613
A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer
Start: Jul 31, 2009
Completion: Not specified
NCT01238952
Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer
Start: Jul 31, 2010
Completion: Mar 31, 2013
NCT01238939
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Start: Aug 31, 2010
Completion: Mar 31, 2014
NCT01475266
Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
Phase: Phase 2/3
Start: Nov 30, 2011
Completion: Apr 30, 2013
NCT01644890
A Phase III Study of NK105 in Patients With Breast Cancer
Phase: Phase 3
Start: Jul 31, 2012
Completion: Jan 31, 2017
NCT02162667
Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer
Role: Collaborator
Start: Jun 30, 2014
Completion: Oct 31, 2018
Loading map...